Satellos Bioscience (STU:0IT) ROCE %: -81.90% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:0IT Satellos Bioscience Inc STU:0IT
35 GF Score
Price €8.00
! 1 Warning Sign
View Full Analysis

What is Satellos Bioscience ROCE %?

Satellos Bioscience STU:0IT -1.84% 35 ROCE % is -81.90% as of Mar. 2026. GuruFocus rates STU:0IT with a GF Score™ of 35/100. The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Satellos Bioscience's annualized ROCE % for the quarter that ended in Mar. 2026 was -81.90%.

Satellos Bioscience  (STU:0IT) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Satellos Bioscience ROCE % Related Terms

Satellos Bioscience ROCE % Historical Data

* Premium members only.

The historical data trend for Satellos Bioscience's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Satellos Bioscience ROCE % Chart

Satellos Bioscience Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial -256.34 -163.66 -71.11 -53.19 -65.72

Satellos Bioscience Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -57.36 -61.51 -65.36 -99.15 -81.90
STU:0IT
35GF Score
Satellos Bioscience Inc STU:0IT
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Satellos Bioscience ROCE % Calculation

Satellos Bioscience's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-22.596/( ( (48.463 - 3.422) + (27.233 - 3.506) )/ 2 )
=-22.596/( (45.041+23.727)/ 2 )
=-22.596/34.384
=-65.72 %

Satellos Bioscience's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-34.748/( ( (27.233 - 3.506) + (65.07 - 3.947) )/ 2 )
=-34.748/( ( 23.727 + 61.123 )/ 2 )
=-34.748/42.425
=-81.90 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -81.90% mean?
Satellos Bioscience (STU:0IT) has a ROCE % of -81.90% as of Mar. 2026.
Is Satellos Bioscience's ROCE % too high?
Satellos Bioscience's current ROCE % is -81.90%. Overall, Satellos Bioscience has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Satellos Bioscience's ROCE % compare to VRTX and REGN?
Satellos Bioscience's ROCE % of -81.90% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Satellos Bioscience's current ROCE % is -81.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Satellos Bioscience stock overvalued right now?
Satellos Bioscience (STU:0IT) has a current ROCE % of -81.90%. The current ROCE % is -81.90%. Satellos Bioscience's overall GF Score™ is 35/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Satellos Bioscience (STU:0IT), the current ROCE % is -81.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Satellos Bioscience Business Description

Address 200 Bay Street, Suite 2800, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
35GF Score

Get the complete analysis for STU:0IT

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.00
Price